These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11100580)

  • 1. [Utilization of generic drugs in Spain and Catalonia: possibilities of savings].
    Torralba Guirao M; Gilabert Perramon A; Peláez de Loño J; Faixedas Brunsoms MT
    Aten Primaria; 2000 Sep; 26(4):210-5. PubMed ID: 11100580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The introduction of generic pharmaceutical products into Galicia].
    Verdejo González A; López-Lázaro L; Rodríguez Moreno C; Piñeiro Lago B; Pereira Martínez ML
    Aten Primaria; 1999 Nov; 24(9):528-32. PubMed ID: 10687221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of prescription of generic drugs for cost containment in pharmaceutics. Analysis in the Community of Navarra].
    Ansa Erice I; Agudo Pascual C; Artazcoz Sanz M; Carnicero Giménez de Azcárate J
    Aten Primaria; 1996 Apr; 17(6):411-4. PubMed ID: 8672647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Generic drugs in Spain: first stage].
    Siles Gutiérrez M; Goldaracena Tanco M
    Aten Primaria; 2000; 26(3):162-8. PubMed ID: 10996949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS; Phillips KA; Gerstenberger EP; Seger AC
    Ann Intern Med; 2005 Jun; 142(11):891-7. PubMed ID: 15941695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State Medicaid programs missed $220 million in uncaptured savings as generic fluoxetine came to market, 2001-05.
    Kelton CM; Chang LV; Kreling DH
    Health Aff (Millwood); 2013 Jul; 32(7):1204-11. PubMed ID: 23836735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumer perceptions of risk and required cost savings for generic prescription drugs.
    Ganther JM; Kreling DH
    J Am Pharm Assoc (Wash); 2000; 40(3):378-83. PubMed ID: 10853539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lost cost savings to the NHS in England due to the delayed entry of multiple generic low-dose transdermal buprenorphine: a case scenario analysis.
    Chapman SR; Aladul MI; Fitzpatrick RW
    BMJ Open; 2019 Aug; 9(8):e026817. PubMed ID: 31375605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine.
    Duh MS; Andermann F; Paradis PE; Weiner J; Manjunath R; Crémieux PY
    Dis Manag; 2007 Aug; 10(4):216-25. PubMed ID: 17718660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study.
    Croker R; Walker AJ; Bacon S; Curtis HJ; French L; Goldacre B
    BMJ Open; 2018 Feb; 8(2):e019643. PubMed ID: 29439078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences between prescription and dispensing of generic medicines in primary care. When the exception is the rule].
    Díez JI; Benounna H; Mayol CV; García RM
    Gac Sanit; 2007; 21(5):404-6. PubMed ID: 17916305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic drug prescriptions following hospital discharge: a prospective study in France.
    Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B
    Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of brands in the prescription of generic drugs at 6 health centers in 2001].
    Carmona Ibáñez G; Guevara Serrano J
    Aten Primaria; 2003 Oct; 32(7):415-9. PubMed ID: 14622554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summaries for patients. Potential savings with substitution of generic drugs for brand-name drugs.
    Ann Intern Med; 2005 Jun; 142(11):I30. PubMed ID: 15941691
    [No Abstract]   [Full Text] [Related]  

  • 17. Encouraging generic use can yield significant savings.
    Zimmerman C
    Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Do generic drugs help control expenditure on hypertension? Apropos of a case].
    García AJ; Martos F; Martín A; Sánchez F
    Gac Sanit; 2004; 18(2):137-44. PubMed ID: 15104975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.